COMPOUNDS CAUSING WEIGHT LOSS

FIELD: medicine. ^ SUBSTANCE: present invention relates to the area of medical products, in particular to the weight loss compound, containing an opioid antagonist naltrexone and bupropione in synergistic effective quantities. The way of weight reduction is besides, described at introduction: naltre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KOVLI MAJKL ALEKSANDR, VEBER EHKARD
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine. ^ SUBSTANCE: present invention relates to the area of medical products, in particular to the weight loss compound, containing an opioid antagonist naltrexone and bupropione in synergistic effective quantities. The way of weight reduction is besides, described at introduction: naltrexone and bupropione or fluoxetine; or nalmephene and fluvoxamine. Also the invention concerns application of the specified combinations for preparation of medicinal agents for weight reduction. ^ EFFECT: synergistic effect of the specified combinations. ^ 20 cl, 3 tbl, 9 ex